» Articles » PMID: 20161290

Inhibition by Methylated Organo-arsenicals of the Respiratory 2-oxo-acid Dehydrogenases

Overview
Specialty Chemistry
Date 2010 Feb 18
PMID 20161290
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Inorganic arsenic that is ingested through drinking water or inhalation is metabolized by biological methylation pathways into organoarsenical metabolites. It is now becoming understood that this metabolism that was formerly considered to be detoxification may contribute as much or more to increasing the toxicity of arsenic. One proposed mode of the toxic action of arsenic and its organoarsenic metabolites is through its binding to proteins and inactivating their enzymatic activity. The classic case has been considered the affinity of the proximal 1,3 sulfhydryl groups of the lipoic acid cofactor of the pyruvate dehydrogenase complex for arsenic. A 2:1 stoichiometry of sulfhydryl to arsenic groups has been measured in proteins and arsenical complexes can be synthesized using free D,L-lipoic acid. The relative importance of this site for arsenic binding has come in to question through the use of methylating bifunctional arsenic complexes that suggested the methylation of an active site histidine may also be important, and the suggestion that arsenic inhibits the pyruvate dehydrogenase complex indirectly by elevating mitochondrial hydrogen peroxide generation. In order to separate the effects of direct trivalent arsenite toxicity from that of hydrogen peroxide and activated oxygen, we studied the inhibition of the PDH complex under conditions that did not generate hydrogen peroxide but did expose the lipoic acid group in its reduced state to arsenicals. We also studied the effects of arsenicals in the inhibition of the α-ketoglutarate dehydrogenase complex. We found that only trivalent arsenical compounds inhibited the activity of both dehydrogenase complexes and only when the lipoic acid was in its reduced form. Arsenite inhibited both enzyme complexes approximately equivalently while monomethylarsenite inhibited the PDH complex to a greater extent than the KGDH complex - although both complexes were very sensitive to inhibition by this complex. Dimethylarsenite inhibition of both complexes was only observed with longer pre-incubation periods. Cumulative inhibition by the reduced arsenical was observed for all complexes indicating a binding mode of inhibition that is dependent upon lipoic acid being in its reduced state.

Citing Articles

Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic transport.

Lorentzon E, Lee J, Masaryk J, Keuenhof K, Karlsson N, Galipaud C bioRxiv. 2025; .

PMID: 39868121 PMC: 11761705. DOI: 10.1101/2025.01.13.632748.


Heavy metals: toxicity and human health effects.

Jomova K, Alomar S, Nepovimova E, Kuca K, Valko M Arch Toxicol. 2024; 99(1):153-209.

PMID: 39567405 PMC: 11742009. DOI: 10.1007/s00204-024-03903-2.


Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Xie S, Liu H, Zhu S, Chen Z, Wang R, Zhang W Cancer Gene Ther. 2024; 31(10):1486-1497.

PMID: 39122830 PMC: 11489083. DOI: 10.1038/s41417-024-00818-z.


As Selectively Induces a Disorder-to-Order Transition in the Metalloid Binding Region of the AfArsR Protein.

Toth A, Sajdik K, Gyurcsik B, Nafaee Z, Weber E, Kele Z J Am Chem Soc. 2024; 146(25):17009-17022.

PMID: 38820242 PMC: 11212059. DOI: 10.1021/jacs.3c11665.


Density Functional Theory Calculation May Confirm Arsenic-Thiol Adhesion as the Primary Mechanism of Arsenical Toxicity.

Tsai M, Lin Y ACS Omega. 2024; 9(12):13975-13981.

PMID: 38559941 PMC: 10976359. DOI: 10.1021/acsomega.3c09269.


References
1.
Gibson G, PARK L, Sheu K, Blass J, Calingasan N . The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int. 2000; 36(2):97-112. DOI: 10.1016/s0197-0186(99)00114-x. View

2.
Haugen A, Kelley R, Collins J, Tucker C, Deng C, Afshari C . Integrating phenotypic and expression profiles to map arsenic-response networks. Genome Biol. 2004; 5(12):R95. PMC: 545798. DOI: 10.1186/gb-2004-5-12-r95. View

3.
Adamson S, Robinson J, Stevenson K . Inhibition of pyruvate dehydrogenase multienzyme complex from Escherichia coli with a radiolabeled bifunctional arsenoxide: evidence for an essential histidine residue at the active site of lipoamide dehydrogenase. Biochemistry. 1984; 23(6):1269-74. DOI: 10.1021/bi00301a039. View

4.
KNOWLES F . Reactions of lipoamide dehydrogenase and glutathione reductase with arsonic acids and arsonous acids. Arch Biochem Biophys. 1985; 242(1):1-10. DOI: 10.1016/0003-9861(85)90472-2. View

5.
Dill K, Adams E, OConnor R, McGOWN E . Structure and dynamics of a lipoic acid-arsenical adduct. Chem Res Toxicol. 1989; 2(3):181-5. DOI: 10.1021/tx00009a010. View